A carregar...
Management of non-small cell lung cancer with EGFR mutation: the role of radiotherapy in the era of tyrosine kinase inhibitor therapy—opportunities and challenges
In recent years, the treatment of advanced non-small cell lung cancer (NSCLC) was greatly promoted by the discovery of oncogenic drivers and the development of targeted therapies specific for these drivers. Somatic mutations in epidermal growth factor receptor (EGFR) are the most common type in pati...
Na minha lista:
| Publicado no: | J Thorac Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5708426/ https://ncbi.nlm.nih.gov/pubmed/29221323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.09.67 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|